99 related articles for article (PubMed ID: 27741429)
21. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
[TBL] [Abstract][Full Text] [Related]
23. IL6 receptor
Wosiski-Kuhn M; Robinson M; Strupe J; Arounleut P; Martin M; Caress J; Cartwright M; Bowser R; Cudkowicz M; Langefeld C; Hawkins GA; Milligan C
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):e631. PubMed ID: 31611269
[TBL] [Abstract][Full Text] [Related]
24. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
[TBL] [Abstract][Full Text] [Related]
25. Altered neuronal activities in the motor cortex with impaired motor performance in adult rats observed after infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Sankaranarayani R; Nalini A; Rao Laxmi T; Raju TR
Behav Brain Res; 2010 Jan; 206(1):109-19. PubMed ID: 19747511
[TBL] [Abstract][Full Text] [Related]
26. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
27. Amyotrophic lateral sclerosis: evidence for intact hepatocyte growth factor/met signalling axis.
Kern MA; Friese M; Grundstrom E; Korhonen L; Wallin A; Aquilonius SM; Askmark H; Schirmacher P; Lindholm D
Cytokine; 2001 Sep; 15(6):315-9. PubMed ID: 11594798
[TBL] [Abstract][Full Text] [Related]
28. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J
J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650
[TBL] [Abstract][Full Text] [Related]
29. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.
Obál I; Klausz G; Mándi Y; Deli M; Siklós L; Engelhardt JI
J Neuroinflammation; 2016 May; 13(1):121. PubMed ID: 27220674
[TBL] [Abstract][Full Text] [Related]
30. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
[TBL] [Abstract][Full Text] [Related]
31. Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.
Chiò A; Mora G; La Bella V; Caponnetto C; Mancardi G; Sabatelli M; Siciliano G; Silani V; Corbo M; Moglia C; Calvo A; Mutani R; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Bondesan P; Garbelli S; Mantovani S; Bendotti C; Tarella C;
Muscle Nerve; 2011 Feb; 43(2):189-95. PubMed ID: 21254083
[TBL] [Abstract][Full Text] [Related]
32. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
[TBL] [Abstract][Full Text] [Related]
33. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
Noto Y; Shibuya K; Sato Y; Kanai K; Misawa S; Sawai S; Mori M; Uchiyama T; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Kasai T; Tokuda T; Nakagawa M; Kuwabara S
Amyotroph Lateral Scler; 2011 Mar; 12(2):140-3. PubMed ID: 21126161
[TBL] [Abstract][Full Text] [Related]
34. Role of platelet derived growth factor (PDGF) in reverting neuronal nuclear and soma size alterations in NSC-34 cells exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Chen YY; Liu XW; Gong TX; Zhang ZY; Liu YE; Zhang YB; Xiang LB; Xia H
Clin Neurol Neurosurg; 2014 May; 120():1-5. PubMed ID: 24731566
[TBL] [Abstract][Full Text] [Related]
35. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
36. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical study of increased tumor necrosis factor-α in the skin of patients with amyotrophic lateral sclerosis.
Fukazawa H; Tsukie T; Higashida K; Fujikura M; Ono S
J Clin Neurosci; 2013 Oct; 20(10):1371-6. PubMed ID: 23850047
[TBL] [Abstract][Full Text] [Related]
38. CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis.
Tateishi T; Yamasaki R; Tanaka M; Matsushita T; Kikuchi H; Isobe N; Ohyagi Y; Kira J
J Neuroimmunol; 2010 May; 222(1-2):76-81. PubMed ID: 20381883
[TBL] [Abstract][Full Text] [Related]
39. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
Liu J; Gao L; Zang D
PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
[TBL] [Abstract][Full Text] [Related]
40. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
